24.08.2013 Views

Abstract book - ESPRAS

Abstract book - ESPRAS

Abstract book - ESPRAS

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

P 4. Dilemas about diagnosis and treatment of melanoma in<br />

our clinical material<br />

Arifi H., Zatriqi V., Buja Z. Berisha A.<br />

Department for Plastic Surgery, Clinical Center, Priština, Kosovo<br />

Opste je poznato u svetu sto se tice diagnostike te lecenja malignog<br />

melanoma odavno prevazidjeno sto nije slucaj kod nas. Dileme oko<br />

diagnostike i ako u posljednjih petljeca usavarsana,nova spoznanja na polju<br />

diagnostike kao:ELM,DELM,UZV ne invazivne metode,te invazivnih<br />

metoda citoloska punkcija pigmentirane promjene preko identifikaciji i<br />

biopsiju santinel limfnog cfora novije su dostignuca koje kod nas zbog<br />

nedostatka tehnickih uvjeta kao i nedovoljnog profesinalizma pogorsavaju<br />

prognozu malignog melanoma.Pogorsanje prognozi doprinosi i nemogucnost<br />

aplikaciji jedinstvenog protokola lecenja malignog melanoma.<br />

Cilj rada: nam je da preko nekoliko klinickih slucajeva da prikazeme koje<br />

su najcesce dileme oko diagnostike i lecenja MM na nasem klinickom<br />

materjalu.<br />

Pitanje koje nama kirurzima muci jeste najvise na polju lecenja, sto se tice<br />

kirurskog tipa lecenja ona uklapa u savremene principe dok preostalji dio<br />

koje pripada polji onkologiji ono je kompljetno otpustena na volju samog<br />

pacienta i obitelja pacienata zbog nedostatka onkoloskog instituta oni su<br />

obavezni da ostalji dio lecenja obavljati van zemlje.<br />

P 5. A multicenter study on resorbable craniomaxillofacial<br />

osteofixation<br />

Ashammakhi N. 1,7 , Dominique R. 2 , Arnaud E 2 ., Marchac D. 2 ,<br />

Ninković M. 3 , Donoway D. 4 , Jones B. 4 , Serlo W. 5 , Laurikainen K. 6 ,<br />

Pertti Törmälä 1 , Timo Waris 7<br />

1<br />

Tampere University of Technology, Institute of Biomaterials, Tampere, Finland.<br />

2<br />

Hopital Necker-Enfants Malades, Craniofacial Unit, Paris, France<br />

3<br />

University of Innsbruck, Department of Plastic and Reconstructive Surgery,<br />

Innsbruck, Austria<br />

4<br />

Great Ormond Street Hospital for Sick Children, Craniofacial Unit, London, UK.<br />

5<br />

Oulu University Hospital, Department of Pediatrics, Oulu, Finland<br />

6<br />

Linvatec Ltd., Tampere, Finland<br />

7<br />

Oulu University Hospital, Department of Surgery, Oulu, Finland<br />

Bioabsorbable osteofixation devices were developed to avoid problems<br />

associated with metals. Bioabsorbable devices are mostly made of the<br />

polymers polylactide (PLA), polyglycolide (PGA) and their copolymers<br />

(PLGA and P(L/DL)LA). Using the technique of self-reinforcement of<br />

bioabsorbable materials, it is possible to manufacture osteofixation devices<br />

with ultra high strength. Self-reinforced (SR) polyglycolide-co-polylactide<br />

(SR-PLGA) 80/20 was selected to make devices (Biosorb TM PDX) for this<br />

study because of its favorable degradation characteristics. The aim of this<br />

study was to evaluate the efficacy of using SR-PLGA (Biosorb TM ) plates and<br />

screws in the fixation of osteotomies in craniomaxillofacial (CMF) surgery.<br />

In a prospective study, 165 patients (161 children and 4 adults) were operated<br />

on in four EU centers (Paris, Innsbruck, London and Oulu) from May 1 st ,<br />

1998 to January 31 st , 2002. Indications included correction of dyssynostotic

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!